Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 300 | 0 | 0 | 0 |
| Gross Profit | N/A | 300 | N/A | N/A | N/A |
| Operating Expenses | 3,295 | 2,427 | 2,062 | 4,440 | 13,132 |
| Operating Income | -3,295 | -2,127 | -2,062 | -4,440 | -13,132 |
| Other Income | 78 | 83 | 66 | 79 | 74 |
| Pre-tax Income | -3,217 | -2,044 | -1,996 | -4,361 | -13,058 |
| Net Income Continuous | -3,217 | -2,044 | -1,996 | -4,361 | -13,058 |
| Net Income | $-3,217 | $-2,044 | $-1,996 | $-4,361 | $-13,058 |
| EPS Basic Total Ops | -0.07 | -0.05 | 1.85 | -0.45 | -1.93 |
| EPS Basic Continuous Ops | -0.07 | -0.05 | 1.98 | -0.45 | -1.93 |
| EPS Diluted Total Ops | -0.07 | -0.05 | 1.85 | -0.45 | -1.93 |
| EPS Diluted Continuous Ops | -0.07 | -0.05 | 1.98 | -0.45 | -1.93 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.05 | N/A | -0.45 | -1.93 |
| EBITDA(a) | $-3,271 | $-2,103 | $-2,035 | $-4,412 | $-13,105 |